(Bloomberg) -- Several publicly traded drug distributors are vying to buy Florida Cancer Specialists & Research Institute, a privately held operator of oncology clinics, people familiar with the ...

For the quarter ended December 2024, Cencora (COR) reported revenue of $81.49 billion, up 12.8% over the same period last year. EPS came in at $3.73, compared to $3.28 in the year-ago quarter.